Article
Investigation of bax, bcl-2, bcl-x and p53 gene polymorphisms in multiple sclerosis.
Journal of neuroimmunology - 1 Aug 2002
Kuhlmann T, Glas M, zum Bruch C, Mueller W, Weber A, Zipp F, Brück W
Abstract excerpt
Clinical course, outcome, radiological features, severity, and histopathology are heterogenous in multiple sclerosis (MS). Since MS is considered to be a polygenic disease, the genetic background may at least partly be responsible for this variability. Some MS cases are histopathologically characterized by a dramatic oligodendrocyte loss that is in part caused by apoptosis. A dysregulated apoptotic elimination of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
